This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $63,111.49, is for the delivery of Rinvoq ER 30 mg tablets through December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award further demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.
Generated 3/31/25, 9:37 AM